Silverberg, Jonathan I., Skayem, Charbel, Le Floc’h, Caroline, Demessant-Flavigny, Ann’Laure, Begolka, Wendy Smith, Taieb, Charles, Kerob, Delphine and Finlay, Andrew ORCID: https://orcid.org/0000-0003-2143-1646
2026.
75196 Nearly half of American children with atopic dermatitis experience significant quality of life impairment, often underestimated by parents [Abstract].
Journal of The American Academy of Dermatology
95
(1 Supp)
, AB311.
10.1016/j.jaad.2026.04.1249
|
Abstract
Atopic dermatitis (AD) is a common skin disease in children, but its impact goes far beyond visible symptoms. To better understand this reality, a study was conducted among American families with children aged 6-12 years living with AD. The aim was to explore how disease severity, parental stress, comorbidities, and family context shape children’s daily lives, using the CDLQI as a reference tool. Two groups of children were assessed: ages 6–9 (n=285) and 10–12 (n=215). Researchers collected a wide range of data: the child ‘gender and responding parent, AD severity [POEM], family burden (ABS-F), parental stress levels (PSS), and most importantly, the children’s own perception of their condition through the CDLQI questionnaire. Statistical analysis revealed several key factors associated with greater impairment in QoL: being in the older age group (10–12years), children’s pessimism about their future, parental stress, as well as comorbid conditions such as attention difficulties and sleep disorders. Unsurprisingly, moderate and severe forms of AD were strongly correlated with higher CDLQI scores. Conversely, a family history of eczema or asthma showed no significant association. Overall, nearly one in two children reported a significant or very significant impact of AD on their daily life. This study highlights the relevance of the CDLQI as a crucial tool for understanding the lived experience of children with AD. It also underscores the gap between parental perception and children’s reality, calling for comprehensive care that addresses not only physical symptoms, but also the psychological and social dimensions of the disease.
| Item Type: | Short Communication |
|---|---|
| Date Type: | Publication |
| Status: | Published |
| Publisher: | Elsevier |
| ISSN: | 0190-9622 |
| Last Modified: | 20 Jul 2026 13:45 |
| URI: | https://orca.cardiff.ac.uk/id/eprint/188345 |
Actions (repository staff only)
![]() |
Edit Item |





Dimensions
Dimensions